Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06238466 · ClinicalTrials.gov registry record · Phase 1

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants With Dyslipidemia

A Phase 1 study of Cardiovascular, sponsored by AstraZeneca.

Active
Registry status
Phase 1
Development phase
96
Enrollment target
5
Study locations

NCT06238466 is a Phase 1 study of Cardiovascular that is active but no longer recruiting, run by AstraZeneca. The registered enrollment target is 96 participants, below the 242-participant average among 8 other Cardiovascular trials with a reported enrollment target (60% lower). The trial reports 5 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06238466, a Phase 1 study of Cardiovascular, is active but no longer recruiting, sponsored by AstraZeneca.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
96 participants
Enrollment target
5
Study locations

Study Summary

A study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of AZD1705 in participants with dyslipidemia.

Conditions Studied

Cardiovascular

Interventions

  • OTHER Placebo
  • DRUG AZD1705

Study Locations (5)

Florida

  • Research Site - Jacksonville
  • Research Site - Winter Park

California

  • Research Site - Glendale

Maryland

  • Research Site - Baltimore

Texas

  • Research Site - San Antonio

Trial Details

FieldValue
Enrollment Target 96 participants
Start Date 2024-01-16
Est. Completion 2026-08-31
Phase Phase 1

Sponsor

AstraZeneca

1,285 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06238466

The ClinicalTrials.gov registry entry for NCT06238466 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 242-participant average among 8 other Cardiovascular trials with a reported enrollment target (60% lower). The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cardiovascular appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06238466 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Florida, California, Maryland.

Frequently Asked Questions

What is clinical trial NCT06238466 about?

NCT06238466 is a clinical study titled "A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants With Dyslipidemia". A study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of AZD1705 in participants with dyslipidemia.

What is the current status of trial NCT06238466?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 96 participants. The study started on 2024-01-16. Estimated completion is 2026-08-31.

What conditions does trial NCT06238466 study?

This clinical trial studies the following conditions: Cardiovascular.

What interventions are being tested in trial NCT06238466?

The interventions under investigation include: Placebo (OTHER), AZD1705 (DRUG).

Who is sponsoring clinical trial NCT06238466?

This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06238466 being conducted?

This trial has 5 study locations across California, Florida, Maryland, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cardiovascular

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cardiovascular

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.